BNR Burning Rock: Rasio Kapitalisasi Pasar marang Nilai Buku

Burning Rock Biotech combines the expertise of biologists and data analysts to drive innovations that, alongside sequencing system sales in China, generate current revenue of 1.69. This chart on GURU.Markets reflects the price trend and serves as an indicator of the asset's dynamics. The business relies on the deep integration of diagnostic tests into the medical protocols of numerous clinics across China.

This ratio compares the market value of Burning Rock Biotech (BNR) to its net assets, revealing either overvaluation or hidden business degradation. A decline in this metric may signal undervaluation, yet it often reflects a drop in return on equity. By analyzing the relative market valuation of capital, an investor determines a fair value balance. This is critical for Burning Rock Biotech (BNR), as reliance on cloud data storage impacts the capital expenditure structure.